Over the past 12 months, 12 insiders at UNITED THERAPEUTICS Corp filed 1469 open-market SEC Form 4 transactions on UTHR: 0 purchases worth $0 and 1469 sales worth $931.5M. Insiders have been net sellers over this period. The most recent filing was on Jul 27, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 27, 26 | Martine A RothblattChairperson & CEO, Director | SELL | 1.8K | $535.04 | $976K |
| Jul 24, 26 | Martine A RothblattChairperson & CEO, Director | SELL | 2.7K | $535.03 | $1.4M |
| Jul 23, 26 | Martine A RothblattChairperson & CEO, Director | SELL | 2.3K | $531.83 | $1.2M |
| Jul 22, 26 | Martine A RothblattChairperson & CEO, Director | SELL | 2.6K | $539.47 | $1.4M |
| Jul 21, 26 | Martine A RothblattChairperson & CEO, Director | SELL | 2.6K | $536.37 | $1.4M |
| Jul 20, 26 | Martine A RothblattChairperson & CEO, Director | SELL | 1.9K | $536.41 | $997K |
| Jul 17, 26 | Martine A RothblattChairperson & CEO, Director | SELL | 2.4K | $542.43 | $1.3M |
| Jul 16, 26 | Martine A RothblattChairperson & CEO, Director | SELL | 3.1K | $537.11 | $1.6M |
| Jul 16, 26 | Paul A MahonEVP & GENERAL COUNSEL | SELL | 3.3K | $536.85 | $1.8M |
| Jul 15, 26 | Martine A RothblattChairperson & CEO, Director | SELL | 3.3K | $533.22 | $1.8M |
| Jul 14, 26 | Martine A RothblattChairperson & CEO, Director | SELL | 3.5K | $532.60 | $1.8M |
| Jul 13, 26 | Martine A RothblattChairperson & CEO | SELL | 2.3K | $542.80 | $1.2M |
| Jul 10, 26 | Martine A RothblattChairperson & CEO | SELL | 1.9K | $553.47 | $1.0M |
| Jul 10, 26 | Jan Malcolm | SELL | 325 | $550.59 | $179K |
| Jul 9, 26 | Martine A RothblattChairperson & CEO | SELL | 2.9K | $555.76 | $1.6M |
| Jul 8, 26 | Martine A RothblattChairperson & CEO | SELL | 1.7K | $560.79 | $946K |
| Jul 7, 26 | Martine A RothblattChairperson & CEO | SELL | 3.4K | $563.24 | $1.9M |
| Jul 6, 26 | Martine A RothblattChairperson & CEO | SELL | 3.4K | $553.90 | $1.8M |
| Jul 2, 26 | Paul A MahonEVP & GENERAL COUNSEL | SELL | 2.2K | $556.36 | $1.2M |
| Jul 2, 26 | Martine A RothblattChairperson & CEO | SELL | 2.9K | $558.37 | $1.6M |
| Jul 1, 26 | Martine A RothblattChairperson & CEO | SELL | 1.5K | $549.14 | $823K |
| Jun 23, 26 | Martine A RothblattChairperson & CEO | SELL | 3.4K | $546.00 | $1.9M |
| Jun 22, 26 | Martine A RothblattChairperson & CEO | SELL | 3.2K | $539.90 | $1.7M |
| Jun 22, 26 | James EdgemondCFO AND TREASURER | SELL | 2.3K | $541.25 | $1.2M |
| Jun 18, 26 | James EdgemondCFO AND TREASURER | SELL | 3.0K | $548.90 | $1.6M |
| Jun 17, 26 | Martine A RothblattChairperson & CEO | SELL | 2.1K | $555.63 | $1.1M |
| Jun 16, 26 | Martine A RothblattChairperson & CEO | SELL | 2.0K | $554.63 | $1.1M |
| Jun 15, 26 | James EdgemondCFO AND TREASURER | SELL | 2.2K | $553.76 | $1.2M |
| Jun 11, 26 | James EdgemondCFO AND TREASURER | SELL | 3.3K | $551.83 | $1.8M |
| Jun 9, 26 | Martine A RothblattChairperson & CEO | SELL | 2.8K | $552.89 | $1.5M |
| Jun 8, 26 | James EdgemondCFO AND TREASURER | SELL | 2.2K | $551.75 | $1.2M |
| Jun 5, 26 | Martine A RothblattChairperson & CEO | SELL | 2.8K | $550.53 | $1.5M |
| Jun 4, 26 | James EdgemondCFO AND TREASURER | SELL | 2.7K | $549.06 | $1.5M |
| Jun 4, 26 | Martine A RothblattChairperson & CEO | SELL | 1.7K | $550.46 | $919K |
| Jun 3, 26 | Martine A RothblattChairperson & CEO | SELL | 2.2K | $551.97 | $1.2M |
| Jun 2, 26 | Martine A RothblattChairperson & CEO | SELL | 2.3K | $543.26 | $1.2M |
| Jun 1, 26 | James EdgemondCFO AND TREASURER | SELL | 2.5K | $554.47 | $1.4M |
| May 28, 26 | James EdgemondCFO AND TREASURER | SELL | 2.0K | $571.48 | $1.1M |
| May 26, 26 | Martine A RothblattChairperson & CEO | SELL | 1.5K | $575.96 | $864K |
| May 26, 26 | James EdgemondCFO AND TREASURER | SELL | 1.9K | $577.13 | $1.1M |
| May 18, 26 | James EdgemondCFO AND TREASURER | SELL | 2.8K | $570.18 | $1.6M |
| May 14, 26 | James EdgemondCFO AND TREASURER | SELL | 3.4K | $577.93 | $2.0M |
| May 11, 26 | James EdgemondCFO AND TREASURER | SELL | 2.1K | $580.45 | $1.2M |
| May 7, 26 | James EdgemondCFO AND TREASURER | SELL | 1.3K | $597.54 | $750K |
| May 4, 26 | James EdgemondCFO AND TREASURER | SELL | 3.0K | $582.29 | $1.7M |
| Apr 30, 26 | James EdgemondCFO AND TREASURER | SELL | 3.0K | $578.76 | $1.7M |
| Apr 27, 26 | James EdgemondCFO AND TREASURER | SELL | 2.4K | $571.92 | $1.4M |
| Apr 23, 26 | James EdgemondCFO AND TREASURER | SELL | 4.0K | $576.62 | $2.3M |
| Apr 22, 26 | James EdgemondCFO AND TREASURER | SELL | 364 | $575.85 | $210K |
| Apr 20, 26 | James EdgemondCFO AND TREASURER | SELL | 1.5K | $585.36 | $885K |
Over the past 12 months, insiders at UNITED THERAPEUTICS Corp filed 0 open-market purchases worth $0 and 1469 sales worth $931.5M on UTHR, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 27, 26.
12 different insiders at UNITED THERAPEUTICS Corp filed open-market SEC Form 4 transactions on UTHR over the last 12 months.
InsiderTape plots every UTHR insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every UNITED THERAPEUTICS Corp insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →